The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the safety and biological activity of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed ovarian cancer.
 
Premal H. Thaker
Consulting or Advisory Role - Celsion
Speakers' Bureau - Zoll (I)
Research Funding - Merck (Inst)
 
Charles A. Leath
Honoraria - Celsion; Precision Therapeutics
Consulting or Advisory Role - Genentech/Roche; Vermillion
Research Funding - AstraZeneca (Inst); Celsion (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celsion (I)
 
William Hampton Bradley
Travel, Accommodations, Expenses - Celsion
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Merrimack
 
Nicholas Borys
Employment - Celsion
Leadership - Celsion
Stock and Other Ownership Interests - Celsion
 
Khursheed Anwer
Employment - Celsion
Leadership - Celsion
Stock and Other Ownership Interests - Celsion
 
Ronald David Alvarez
Honoraria - Clovis Oncology
Research Funding - Celsion (Inst)